Ranitidine Recall: Time to know that other drugs do not have NDMA |
Editorial
eMediNexus Coverage from: 
Ranitidine Recall: Time to know that other drugs do not have NDMA

15 Read Comments                

On September 13, 2019, the US FDA announced that preliminary tests found low levels of N-nitrosodimethylamine (NDMA) in ranitidine, a heartburn medication. Novartis (through its generic division, Sandoz) and Apotex announced that they were recalling all of their generic ranitidine products sold in the US. GSK has also recalled its ranitidine medication sold in global markets including in India.Ranitidine is an H2 (or histamine-2) blocker and is commonly used to relieve and prevent heartburn...
To read the complete article ,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now